YaleCourses |
(0) (0 Votes)
|
Views: (609) Date: (08-04-10) Time: (00:50:43) |
Description: Freshman Organic Chemistry (CHEM 125) The chemical mode of action of omeprazole is expected to be insensitive to its stereochemistry, making clinical trials of the proposed virtues of a chiral switch crucial. Design of the clinical trials is discussed in the context of marketing. Otolaryngologist Dr. Dianne Duffey provides a clinician's perspective on the testing and marketing of pharmaceuticals, on the FDA approval process, on clinical trial system, on off-label uses, and on individual and institutional responsibility for evaluating pharmaceuticals. Complete course materials are available at the Open Yale Courses website: open.yale.edu This course was recorded in Fall 2008.